Testolido 250 (4ml) Injection – Product Overview

Testolido 250 is a sterile pharmaceutical-grade injectable solution that delivers a standardized dose of testosterone within a 4ml ampoule. The product is packaged in sealed glass containers to preserve potency and prevent contamination. Each box contains either ten, twenty, or thirty ampoules, allowing clinics and pharmacies to stock according to patient volume. Manufactured by Kachhela Medex Pvt. Ltd., a company registered under Indian pharmaceutical regulations, Testolido 250 adheres to Good Manufacturing Practice (GMP) standards. The medication is indicated for adult males diagnosed with clinically low testosterone levels secondary to primary or secondary hypogonadism. Its formulation is intended for deep intramuscular injection, providing a depot effect that sustains therapeutic hormone levels for up to several weeks.

What is Testolido 250 (4ml) Injection

Testolido 250 belongs to the therapeutic class of androgen replacement agents. The active ingredient is a synthetic form of testosterone, the principal male sex hormone responsible for the development and maintenance of masculine characteristics. In clinical practice, the compound is used to compensate for endogenous testosterone deficiency that may arise from testicular failure, pituitary insufficiency, or genetic conditions. The 4ml ampoule contains 250 milligrams of testosterone, a dose calibrated to achieve physiologic serum concentrations when administered according to prescribed intervals. The medication is supplied in a ready‑to‑use format, eliminating the need for additional dilution or preparation steps before administration.

Uses and Benefits

Uses and Benefits of Testolido 250 revolve around the restoration of normal testosterone activity in men who experience symptoms associated with hypogonadism. Patients may report fatigue, reduced libido, diminished muscle strength, increased body fat, and mood disturbances when testosterone levels fall below the reference range. By delivering a calibrated dose of the hormone, Testolido 250 can alleviate these symptoms, supporting improvements in energy, exercise tolerance, and sexual function. In addition, adequate testosterone levels contribute to the maintenance of bone mineral density, helping to reduce the risk of osteoporosis in susceptible individuals. When integrated with lifestyle modifications and regular monitoring, testosterone replacement therapy using Testolido 250 can enhance overall quality of life and functional capacity.

How It Works

The pharmacodynamics of Testolido 250 are characterized by a depot release profile after intramuscular injection. Following administration, the testosterone molecule is gradually liberated from the oily vehicle, leading to a slow but sustained increase in serum testosterone concentrations. This controlled release mimics the natural pulsatile secretion pattern of the hypothalamic‑pituitary‑gonadal axis, thereby minimizing abrupt spikes that could provoke supraphysiologic effects. The sustained hormone levels enable the androgen receptor to be activated in target tissues such as skeletal muscle, adipose tissue, and the urogenital tract, facilitating protein synthesis, lipolysis, and the maintenance of secondary sexual characteristics. Therapeutic efficacy is achieved when circulating testosterone remains within the physiologic range of 300–1000 ng/dL, as determined by laboratory assays.

Dosage Guidelines

Dosage of Testolido 250 must be individualized based on baseline hormonal assessments and patient‑specific factors. The standard starting regimen consists of one 4ml ampoule injected intramuscularly at weeks 0, 2, and 4, after which the interval may be extended to every three or four weeks depending on serum testosterone measurements and clinical response. Physicians typically obtain a baseline total testosterone level before initiating therapy and repeat the test after four to six weeks to evaluate adequacy of dosing. If levels remain below the target range, the dosing interval may be shortened, or the dose may be adjusted upward under medical supervision. Ongoing monitoring includes periodic evaluation of prostate‑specific antigen (PSA), hematocrit, and lipid profile to detect potential adverse trends early.

Side Effects

Side Effects associated with Testolido 250 are generally mild when the medication is used appropriately, but they can include local reactions such as pain, erythema, or induration at the injection site, which usually resolve within a few days. Systemic adverse effects may comprise acne, oily skin, increased facial or body hair, and fluid retention, leading to modest weight gain. In some individuals, the therapy can exacerbate sleep apnea or elevate red blood cell production, resulting in elevated hematocrit. Rarely, patients may experience mood swings, aggression, or depressive symptoms. Any persistent or severe side effects should be reported to a healthcare provider, who may modify the treatment plan or discontinue therapy if necessary.

Warnings and Precautions

Warnings and Precautions require careful patient selection and baseline work‑up. Testolido 250 is contraindicated in men with active prostate cancer, severe cardiovascular disease, or untreated obstructive sleep apnea, as the therapy may exacerbate these conditions. Patients with significant hepatic impairment should be monitored closely, as testosterone metabolism may be compromised. Prior to initiation, a digital rectal examination and PSA testing are recommended to screen for occult prostate pathology. Women who are pregnant, breastfeeding, or of child‑bearing potential must avoid exposure, as inadvertent hormonal transfer could cause virilization of a female fetus or infant. Proper injection technique, sterile needle use, and safe disposal of sharps are essential to prevent infection and accidental needlestick injuries.

Frequently Asked Questions

1. What condition does Testolido 250 treat?
   Testolido 250 is indicated for male hypogonadism, a clinical condition marked by insufficient endogenous testosterone production.
2. How is the medication administered?
   Each 4ml ampoule is injected intramuscularly into a large muscle group such as the gluteus maximus or deltoid, typically every two to four weeks.
3. Can the dose be adjusted without medical supervision?
   No, dosage modifications must be performed only after consultation with a qualified healthcare professional to avoid hormonal imbalances.
4. Are there any dietary restrictions while using Testolido 250?
   No specific dietary limitations are required, but maintaining a balanced diet and healthy body weight can optimize therapeutic outcomes.
5. Where can I find more information about testosterone therapy?
   Authoritative resources such as the NIH Office of Dietary Supplements and the FDA provide evidence‑based guidance on hormone replacement treatments.

For additional details, healthcare professionals may refer to the U.S. Food and Drug Administration or consult peer‑reviewed literature via PubMed.

Always consult a qualified healthcare professional before initiating, modifying, or discontinuing any medication. Proper storage at controlled room temperature and safe disposal of used needles are essential to maintain product integrity and patient safety.

Related Products

• Iverhuman 1% 30g (Ivermectin)
• Nokrono 500 mg (Disulfiram)
• Lodonak 1.5 mg (Naltrexone)
• Lodonak
• Lodonak 3 mg (Naltrexone)
• Nalcip 50 mg (Naltrexone)
• Disulfiram 500mg (Generic)
• Kaymedorol 4 Mg
• Kaymedorol 16 Mg (Methylprednisolone)
• Kaymedorol 8 Mg (Methylprednisolone)
• Methylprednisolone 8 Mg (Generic)
• Methylprednisolone 16 Mg (Generic)